glp 1 approved for prediabetes More data on Retatrutide dropped today at the ADA conference!! Reta is an investigational -not FDA yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase GLP-1 Drugs for Weight Loss:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19


























